Komori
Shin-Etsu Chemical (4063) · FactFull-Year R&D Expenses Updated

Research and development expenses for the first quarter

First written in FY2018-Q1. . Latest entry: FY2026.

32entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q1 – FY20262017: 220172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

49 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2026Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥77,819 million.」

    Research and development expenses for FY2026 were ¥77,819 million, up from ¥73,129 million in the previous fiscal year.
  2. FY2026-H1Interim-period research and development expenses updatedAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the current interim consolidated accounting period were ¥37,252 million.」

    Research and development expenses for FY2026-H1 were ¥37,252 million, up from ¥33,822 million in the same period of the previous year.
  3. FY2025Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥73,129 million.」

    Research and development expenses for FY2025 were ¥73,129 million, up from ¥65,785 million in the previous fiscal year.
  4. FY2025-H1Interim-period research and development expenses updatedAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the current interim consolidated accounting period were ¥33,822 million.」

    Research and development expenses for FY2025-H1 were ¥33,822 million, up from ¥32,944 million in the previous interim consolidated accounting period.
  5. FY2024Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥65,785 million.」

    Research and development expenses for FY2024 were ¥65,785 million, down from ¥67,201 million in the previous fiscal year.
  6. FY2024-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥48,933 million.」

    Research and development expenses for FY2024-Q3 cumulative were ¥48,933 million.
  7. FY2024-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥31,757 million.」

    Research and development expenses for FY2024-Q2 cumulative were ¥31,757 million, down from ¥32,944 million in the same period of the previous year.
  8. FY2024-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥15,548 million.」

    Research and development expenses for FY2024-Q1 were ¥15,548 million.
  9. FY2023Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥67,201 million.」

    Full-year research and development expenses were ¥67,201 million, up from ¥62,455 million in the previous fiscal year.
  10. FY2023-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥48,202 million.」

    Research and development expenses for FY2023-Q3 cumulative were ¥48,202 million.
  11. FY2023-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥32,944 million.」

    Research and development expenses for the second quarter of the current consolidated cumulative period were ¥32,944 million.
  12. FY2023-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥16,138 million.」

    Research and development expenses for FY2023-Q1 were ¥16,138 million.
  13. FY2022Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥62,455 million.」

    Full-year research and development expenses were ¥62,455 million, up from ¥51,264 million in the previous fiscal year.
  14. FY2022-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥46,292 million.」

    Research and development expenses for FY2022-Q3 cumulative were ¥46,292 million.
  15. FY2022-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥27,327 million.」

    Research and development expenses for FY2022-Q2 cumulative were ¥27,327 million.
  16. FY2022-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥14,016 million.」

    Research and development expenses for FY2022-Q1 were ¥14,016 million.
  17. FY2021Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥51,264 million.」

    Full-year research and development expenses were ¥51,264 million, up from ¥48,536 million in the previous fiscal year.
  18. FY2021-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥37,483 million.」

    Research and development expenses for FY2021-Q3 cumulative were ¥37,483 million.
  19. FY2021-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥24,520 million.」

    Research and development expenses for FY2021-Q2 were ¥24,520 million, down from ¥26,761 million in the same period of the previous year.
  20. FY2021-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥12,338 million.」

    Research and development expenses for FY2021-Q1 were ¥12,338 million.
  21. FY2020Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥48,536 million.」

    Research and development expenses for FY2020 were ¥48,536 million, down from ¥56,436 million in the previous fiscal year.
  22. FY2020-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥36,210 million.」

    Research and development expenses for FY2020-Q3 cumulative were ¥36,210 million.
  23. FY2020-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥24,716 million.」

    Research and development expenses for FY2020-Q2 cumulative were ¥24,716 million, down from ¥26,761 million in the same period of the previous year.
  24. FY2020-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥12,913 million.」

    Research and development expenses for FY2020-Q1 were ¥12,913 million, down from ¥13,739 million in the same period of the previous year.
  25. FY2019Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥56,436 million.」

    Research and development expenses for FY2019 were ¥56,436 million, up from ¥51,768 million in the previous fiscal year.
  26. FY2019-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the third quarter of the current consolidated cumulative period were ¥41,344 million.」

    Research and development expenses for FY2019-Q3 cumulative were ¥41,344 million.
  27. FY2019-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the second quarter of the current consolidated cumulative period were ¥26,761 million.」

    Research and development expenses for FY2019-Q2 cumulative were ¥26,761 million.
  28. FY2019-Q1Update to first-quarter R&D expensesAnnual report

    「Research and development expenses for the Group, comprising the Company and its consolidated subsidiaries, during the first quarter of the current consolidated cumulative period were ¥13,739 million.」

    Research and development expenses for FY2019-Q1 were ¥13,739 million.
  29. FY2018Full-Year R&D Expenses UpdatedAnnual report

    「Research and development expenses for the Group as a whole during the current consolidated fiscal year were ¥51,768 million.」

    Research and development expenses for the Group as a whole for FY2018 were ¥51,768 million.
  30. FY2018-Q3Updated cumulative R&D expenditure for the third quarterAnnual report

    「Research and development expenses for the Group as a whole during the third quarter of the current consolidated cumulative period were ¥38,143 million.」

    Research and development expenses for the Group as a whole in the third quarter of the current consolidated cumulative period were ¥38,143 million.
  31. FY2018-Q2Updated cumulative R&D expenditure for the second quarterAnnual report

    「Research and development expenses for the Group as a whole during the second quarter of the current consolidated cumulative period were ¥23,739 million.」

    Research and development expenses for the Group as a whole in the second quarter of the current consolidated cumulative period were ¥23,739 million.
  32. FY2018-Q1First statedAnnual report

    「Research and development expenses for the Group as a whole during the first quarter of the current consolidated cumulative period were ¥12,260 million.」

    Research and development expenses for the Group as a whole in the first quarter of the current consolidated cumulative period were ¥12,260 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shin-Etsu Chemical's next results are scheduled for 2026-10-27. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and development expenses for the first quarter | Shin-Etsu Chemical Co.,Ltd. (4063) | Komori